Genzyme Renagel Marketing Message Will Focus On Lipid-Lowering Effect
This article was originally published in The Pink Sheet Daily
Executive Summary
Phosphate binder may face competition from Shire’s Fosrenol and Amgen’s cinacalcet in the near term. Genzyme views cinacalcet as a "complementary product" rather than a direct competitor.